MAPT and Alzheimer disease: Monitoring the progression of tau and its effect on neuronal reorganization due to tau-induced neurodegeneration in vivo is a key requirement in understanding the progression of AD and determining the efficacy of current therapeutic attempts to target tauopathies (de Calignon et al., 2012, Ahmed et al., 2014).